Switch View
© Globe Newswire
06.10.2025
ISIN: US09075X1081
Biodesix Inc
BDSX
LISTED
NASDAQ
Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit
News Preview
Biodesix partners with three leading Lung Health organizations to bring education and advocacy to healthcare professionals and patients...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: US7574683014
Redhill Biopharma Ltd
RDHL
LISTED
NASDAQ
RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia®
News Preview
The deal aims to accelerate Talicia's entry into new Middle East markets
Under the terms of the agreement RedHill will receive $500,000 in guaranteed payments, including a $250,000 upfront payment and $250,000 in fixed payments due within 18 months, plus a mini...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: AU000000CSL8
CSL Limited
CSL
LISTED
ASX
CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B
News Preview
OTTAWA, Ontario, Oct. 6, 2025 /CNW/ -- CSL Behring Canada Inc., a business unit of global biopharma leader CSL, today announced that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public reimbursement of HEMGENIX® (etranacogene dezaparvovec). HEMGENIX is the fi...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
06.10.2025
ISIN: US04962H2094
Atossa Therapeutics, Inc.
ATOS
LISTED
NASDAQ
Atossa Therapeutics Streamlines EVANGELINE Breast Cancer Clinical Trial to Prioritize for 2026 NDA-Enabling Activities
News Preview
Changes are expected to reduce future study costs, accelerate objective readouts, and extend operating runway under current plans
SEATTLE, Oct. 6, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS; "Atossa" or the "Company), a clinical-stage biopharma...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
06.10.2025
ISIN: US90184D1000
Twist Bioscience Corp
TWST
LISTED
NASDAQ
Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, and Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced the launch of Twist’s new Trinity Freestyle Fast Hybridization workflow for Element's AVITI™ sequencing platforms, a user-friendly, end-to-end seq...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity to Hold Earnings Call on Monday, October 27, 2025
News Preview
Revvity, Inc. (NYSE: RVTY), today announced that it will release its third quarter 2025 financial results prior to market open on Monday, October 27, 2025. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer,...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US03815U6073
Applied DNA Sciences, Inc.
BNBX
LISTED
NASDAQ
Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy
News Preview
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a biotechnology company advancing a yield focused BNB digital asset treasury strategy and commercializing nucleic acid production solutions, today announced that it will change its ticker symbol on the Nasdaq Capital Market (“Nasdaq”) from “APDN” to “BNBX”, effective at th...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US2975841048
Estrella Immunopharma, Inc.
ESLA
LISTED
NASDAQ
Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements
News Preview
Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, announces that, as previously disclosed in its Current Report on Form 8-K filed on September 29, 2025, the Company has regained com...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US03969F1093
Arcus Biosciences Inc
RCUS
LISTED
NYSE
Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event
News Preview
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced new monotherapy data for casdatifan, a HIF-2a inhibitor with best-in-class potential, in late-line metastatic clear cell renal cell carcinoma (ccRCC...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US03168L1052
Amneal Pharmaceuticals Inc
AMRX
LISTED
NASDAQ
Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)
News Preview
Kashiv BioSciences, LLC, a fully-integrated biopharmaceutical company, announced that they have submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), and the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA), for ADL-018, a proposed biosimilar to XOLAIR® (omalizumab...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US1241551027
Butterfly Network Inc
BFLY
LISTED
NYSE
Butterfly Network Launches First-to-Market Artificial Intelligence Gestational Age Tool in Sub-Saharan Africa to Improve Maternal Health
News Preview
Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced the launch of a first-of-its-kind Gestational Age artificial intelligence (AI) tool in Malawi and Uganda. The tool is Butterfly’s latest innovation to improve mat...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today highlighted commentary from numerous independent industry analysts who recognize that STAAR’s merger with Alcon (SIX/NYSE: ALC) – and the compelling, certain, premium cash value it prov...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
06.10.2025
ISIN: US09073Q3039
Scinai Immunotherapeutics, Ltd.
SCNI
LISTED
XETRA
Scinai Awarded Israel Innovation Authority Grant to Expand Fill-and-Finish CDMO Capabilities
News Preview
Grant funds two-thirds of a
NIS 1.23 million ($373K) project to strengthen Scinai Bioservices' small-batch fill and finish capabilities, addressing a critical need among early-stage biotech companies in Israel and abroad
JERUSALEM, Oct. 6, 202...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics Appoints Ian F. Smith as Chief Executive Officer
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today announced that its Board of Directors has appointed Ian F. Smith as Chief Executive Officer (CEO). Mr. Smith has served as Interim CEO since March 2025 and as a member of Stoke’s Boa...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement with respect to the flawed, misleading, and misinformed claims recently made by Broadwood Partners, L.P.:
Broadwood’s recent presentation recycles flawe...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US6024961012
MiMedx Group Inc
MDXG
LISTED
NASDAQ
MIMEDX Announces Launch of EPIXPRESS®
News Preview
Next-Generation, Lyophilized Human Placental Allograft Further Expands Company’s Broad Portfolio of Advanced Wound Care (“AWC”) Products Next-Generation, Lyophilized Human Placental Allograft Further Expands Company’s Broad Portfolio of Advanced Wound Care (“AWC”) Products...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD
News Preview
Over 1,200 participants enrolled in ATMOSPHERE® and ASCENT® pivotal trials, representing largest global gene therapy program ever conducted
Subretinal surabgene lomparvovec on track to be first gene therapy for wet AMD...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US81726A1007
Senti Biosciences, Inc.
SNTI
LISTED
NASDAQ
Senti Bio to Present at BioJapan
News Preview
In-person presentation on Thursday, October 9th at 11:30 AM JST In-person presentation on Thursday, October 9th at 11:30 AM JST...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
News Preview
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced new innovations and products that will be featured at The American Society f...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US28106W1036
Editas Medicine Inc
EDIT
LISTED
NASDAQ
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
News Preview
CAMBRIDGE, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced an oral presentation at the upcoming European Society of Gene and Cell Therapy (ESGCT) Congress, to be held October 7-10, 2025, in Seville,...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US36254L2097
GT Biopharma Inc
GTBP
LISTED
NASDAQ
GT Biopharma to Participate in the Centurion One Capital 3rd Annual Bahamas Summit
News Preview
SAN FRANCISCO, CALIFORNIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager TriKE® platform, today announced that Michael Breen, Executive Chairman and Chief...
Themefolio
Profiler
Peergroup
© Newsfile
06.10.2025
ISIN: CA68405H1001
Optimi Health Corp
OPTI
LISTED
CSE
Optimi Health's Psilocybin Capsules Selected for Medibank Insurance Program
News Preview
Australia's largest private health insurer expands its AUD $10M psychotherapy program to cover psilocybin for Treatment-Resistant Depression, building on earlier MDMA coverage for PTSDVancouver, British Columbia--(Newsfile Corp. - October 6, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian GM...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the appointments of Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025.
“I am pleased to welcome Bilal and Linea to our leadership team as we advance the global launch of EKTERLY,” said Ben Palleiko, Chief Executive Officer of Kal...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US69608A1088
Palantir Technologies, Inc.
PLTR
LISTED
NASDAQ
OneMedNet Selects Palantir to Advance Healthcare AI and Data Analytics
News Preview
OneMedNet Corporation (Nasdaq: ONMD) has selected Palantir Technologies (Nasdaq: PLTR) to transform the healthcare AI and Real-World Data (RWD) analytics marketplace. Palantir’s Artificial Intelligence Platform will provide the infrastructure for OneMedNet’s iRWD™ near real-time AI powered provider network (“network”) enabling OneMedNet to empower...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced it has initiated three Phase 2b trials evaluating the safety and efficacy of tulisokibart (MK-7240), an investigational humanized monoclonal antibody targeting tumor necrosis factor (TNF)-like cytokine 1A (TL1A), in patients with three immune-mediated inflammatory d...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US59564R6099
Biodexa Pharmaceuticals plc
BDRX
LISTED
NASDAQ
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025
News Preview
October 6, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US82711P2011
Silo Pharma, Inc.
SILO
LISTED
NASDAQ
Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)
News Preview
Company invests in DeSci blockchain innovation and purchases native coin of ResearchHub, a decentralized science platform co-founded by Coinbase CEO, Brian Armstrong...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors
News Preview
MaxCyte’s Flow Electroporation® Technology will support efficient gene delivery to advance Moonlight Bio’s engineered T cell therapies MaxCyte’s Flow Electroporation® Technology will support efficient gene delivery to advance Moonlight Bio’s engineered T cell therapies...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US6294441000
NRx Pharmaceuticals, Inc.
NRXP
LISTED
NASDAQ
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference
News Preview
WILMINGTON, Del., Oct. 06, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, will present at the Noble Capital Mar...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5
News Preview
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US58468P2065
MediciNova Inc
MNOV
LISTED
NASDAQ
MediciNova to Present at the LD Micro Main Event XIX Investor Conference
News Preview
LA JOLLA, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that Yuichi Iwaki, M.D., Ph.D., President and CEO, and David H. Crean, Ph.D., Chief Business Officer,...
Themefolio
Profiler
Peergroup
© Newsfile
06.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness Signs 1st Ottawa, Ontario Real-Estate Location with Multi-Unit & Multi-Branded Franchisee
News Preview
Toronto, Ontario--(Newsfile Corp. - October 6, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada is pleased to announce that an existing multi-unit franchisee of Via Cibo has successfully secured a real estate location for Heal Wellne...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health and its Hospitals Earn Record-Breaking 20 Awards and Accolades in Q3
News Preview
HOUSTON, Oct. 6, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physicia...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US21077P1084
Context Therapeutics Inc.
CNTX
LISTED
NASDAQ
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
News Preview
PHILADELPHIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today announced two posters will be presented at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Me...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US57055L1070
Marker Therapeutics, Inc.
MRKR
LISTED
NASDAQ
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program
News Preview
Marker Therapeutics initiated Phase 1 RAPID study to investigate Multi-Antigen Recognizing (MAR) T cells as an Off-the-Shelf (OTS) product to accelerate time to treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US00534A1025
Invivyd Inc
IVVD
LISTED
NASDAQ
Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
News Preview
NEW HAVEN, Conn., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application and provided feedback to advance the company’s REVOLUTION clinical program, Invivyd’s development program for VYD2311, a vaccine alte...
Themefolio
Profiler
Peergroup
© EQS Newswire
06.10.2025
ISIN: DE000A40AEG0
Pentixapharm Holding AG
PTP
LISTED
XETR
Pentixapharm präsentiert erweiterte CXCR4-Radiopharmazeutika-Plattform mit neuen klinischen Ergebnissen auf EANM 2025 Kongress
News Preview
Pentixapharm präsentiert erweiterte CXCR4-Radiopharmazeutika-Plattform mit neuen klinischen Ergebnissen auf EANM 2025 Kongress
Klinische Daten aus unabhängigen prüferinitiierten Studien mit [⁶⁸Ga]Ga-PentixaFor zeigen Potenzial zur verbesserten Diagnostik des Primären Hyperaldosteronismus (PA)
Erste klinische Ergebnisse mit [¹⁷⁷Lu]Lu-PentixaTh......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.10.2025
ISIN: DE000A40AEG0
Pentixapharm Holding AG
PTP
LISTED
XETR
Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025
News Preview
Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025
Clinical data from independent investigator-initiated studies using [⁶⁸Ga]Ga-PentixaFor demonstrate potential to improve diagnosis in Primary Aldosteronism
First-in-human findings with [¹⁷⁷Lu]Lu-PentixaTher in bladder cancer show early......
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US4158581094
Harrow Inc
HROW
LISTED
NASDAQ
ImprimisRx Announces Leadership Changes
News Preview
Frank Mullery Appointed Chief Executive Officer of ImprimisRx...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US68232V8019
Traws Pharma Inc.
TRAW
LISTED
NASDAQ
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
News Preview
NEWTOWN, Pa., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, today announced the appointment of John Leaman, MD, to its board of director...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US15117F3029
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Cellectar Biosciences Announces European Medicines Agency (EMA) Confirms Eligibility to File for Conditional Marketing Authorization (CMA) for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) Waldenstrom Macroglobulinemia (WM)
News Preview
Following Scientific Advice and Guidance from Scientific Advice Working Party (SAWP) of EMA, Submission of CMA Application for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) WM Expected in Early 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US55234L1052
Lyra Therapeutics, Inc.
LYRA
LISTED
NASDAQ
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study
News Preview
Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission ...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US87583X1090
Tango Therapeutics Inc
TNGX
LISTED
NASDAQ
Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025
News Preview
Company to present three posters at SITC Annual Meeting 2025 Company to present three posters at SITC Annual Meeting 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: US5787841007
Maze Therapeutics Inc
MAZE
LISTED
NASDAQ
Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors
News Preview
Maze Therapeutics appoints industry veteran Hervé Hoppenot as Chairman of the Board of Directors...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 6, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASDA...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies (OTC PINK:MDCE) Launches Next-Generation AI Validation Program Targeting Clinical-Grade Accuracy
News Preview
MESA, AZ / ACCESS Newswire / October 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced its plan to benchmark its upcoming AI diagnostic model against the HAM10000 public dermatology dataset to validate its image recognition architecture for detecting various skin lesion types. The benchmarking process will help evaluate model prec...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 6, 2025 / Lunai Bioworks (Nasdaq:LNAI) today announced a major advance in Alzheimer's research: its AI platform, Augusta™, achieved up to a 35% improvement in diagnostic accuracy by combining MRI scans with genetic and metabolic data. The company is launching a preclinical Alzheimer's progra...
Themefolio
Profiler
Peergroup
© Newsfile
06.10.2025
ISIN: CA24463V1013
Defence Therapeutics Inc.
DTC
LISTED
CSE
Defence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025
News Preview
Montreal, Quebec--(Newsfile Corp. - October 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce its participation at CPHI Worldwide 2025, taking place in Frankfurt, Germany from October 28-30, 20...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID)
News Preview
Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support (PS) (comprised of total parenteral nutrition and supplementary IV fluids) of approximately 37% SAN FRANCISCO, CA, AL / ACCESS Newswire / October 6, 2025 / Jaguar Health, Inc. (N...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
News Preview
LONDON, UK and REYKJAVIK, ICELAND (OCTOBER 6, 2025) — Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
News Preview
LONDON and REYKJAVIK, Iceland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: US60785L2079
Modular Medical, Inc.
MODD
LISTED
NASDAQ
Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System
News Preview
-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps SAN DIEGO, CA, CA / ACCESS Newswire / October 6, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology ta...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: US7389201077
Aspire Biopharma Holdings, Inc
ASBP
LISTED
NASDAQ
Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform
News Preview
ESTERO, FLORIDA / ACCESS Newswire / October 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced the filing of an omnibus patent application with the U.S. Patent and Trademark Office for its sublingual delivery t...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
ISIN: JP3475350009
Daiichi Sankyo Co Ltd
45680
LISTED
XJPX
DATROWAY® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival as First-Line Therapy for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
News Preview
Positive topline results from the TROPION-Breast02 phase 3 trial showed DATROWAY® (datopotamab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival (OS) and progression-free survival (PFS) compared to investigator’s choice of chemotherapy as first-line treatme...
Themefolio
Profiler
Peergroup
© PR Newswire
06.10.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
News Preview
NEW YORK, Oct. 6, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: DE000A40AEG0
Pentixapharm Holding AG
PTP
LISTED
XETR
Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025
News Preview
Clinical data from independent investigator-initiated studies using [⁶⁸Ga]Ga-PentixaFor demonstrate potential to improve diagnosis in Primary AldosteronismFirst-in-human findings with [¹⁷⁷Lu]Lu-PentixaTher in bladder cancer show early therapeutic activity, further validating CXCR4 as a clinically relevant target BERLIN, DE / ACCESS Newswire /...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 October 2025 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System
News Preview
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche receives CE Mark for AI-based Kidney Klinrisk Algorithm(1) and launches new comprehensive chronic kidney disease (CKD) algorithm panel
News Preview
Basel, 6 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY), in collaboration with KlinRisk, Inc., has received the CE-mark for the first AI-based risk stratification tool to assess progressive decline in kidney function. This milestone allows Roche to introduce the Chronic Kidney Disease (CKD) algorithm panel on its navify® Algorithm Suite to suppo...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.10.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Announces Clearance to Initiate Pediatric Enrolment
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.MD A...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
